新闻
2024-03-27
全球首批!首个CLDN18.2单抗获批上市,一线治疗胃癌
临床结果上市批准临床成功
2024-03-26
Matinas BioPharma Announces Positive in vivo Safety Data with its Oral LNC-Docetaxel Formulation
临床结果财报
2024-03-26
Tonix Pharmaceuticals Receives Rare Pediatric Disease Designation from the FDA for TNX-2900 for the Treatment of Prader-Willi Syndrome
上市批准并购优先审批孤儿药
2024-03-26
首款!复发风险降低98.6%,阿斯利康抑制剂再获FDA批准
临床结果临床3期
2024-03-26
石药集团「司美格鲁肽」减重适应症获批临床
上市批准临床申请
2024-03-26
Sosei Heptares Regains Full Ownership from GSK of HTL0027477, a Clinic-ready, First-in-Class Oral GPR35 Agonist for Inflammatory Bowel Disease
临床1期免疫疗法
2024-03-26
恒瑞医药「氟唑帕利」+「阿帕替尼」联合疗法拟纳入突破性治疗品种
突破性疗法申请上市ASH会议临床结果
2024-03-25
NMD Pharma Receives FDA IND Clearance to initiate a Phase 2b Clinical Trial of NMD670 in Generalized Myasthenia Gravis Patients in the US
孤儿药临床申请
2024-03-25
Novartis Fabhalta® (iptacopan) receives positive CHMP opinion as first oral monotherapy for adult patients with paroxysmal nocturnal hemoglobinuria (PNH)
临床结果上市批准ASH会议
2024-03-25
Three Patients with Invasive Fusarium Infection in Matinas BioPharma’s Oral MAT2203 Compassionate/Expanded Use Access Program Achieve Complete Clinical Response
临床结果寡核苷酸